Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-25-000013
Filing Date
2025-04-24
Accepted
2025-04-24 10:13:32
Documents
4
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq1.htm 6-K 12923
2 EX-99.1 pressreleaseq12025english.htm EX-99.1 738445
3 GRAPHIC fsridynmyoja6nwywy2m1otazoa.gif GRAPHIC 2870
4 GRAPHIC imagea.jpg GRAPHIC 177740
  Complete submission text file 0001121404-25-000013.txt   1001530
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25864947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)